Correlation Between Joint Stock and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Joint Stock and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Joint Stock and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Joint Stock and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Joint Stock and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Joint Stock with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Joint Stock and Mineralys Therapeutics,.

Diversification Opportunities for Joint Stock and Mineralys Therapeutics,

0.35

Correlation Coefficient

Joint Stock  Mineralys Therapeutics,

Weak diversification

The 3 months correlation between Joint and Mineralys is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Joint Stock and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Joint Stock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Joint Stock are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Joint Stock i.e., Joint Stock and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Joint Stock and Mineralys Therapeutics,

Given the investment horizon of 90 days Joint Stock is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Joint Stock is 1.32 times less risky than Mineralys Therapeutics,. The stock trades about -0.09 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,195  in Mineralys Therapeutics, Common on October 3, 2024 and sell it today you would earn a total of  36.00  from holding Mineralys Therapeutics, Common or generate 3.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Joint Stock  vs.  Mineralys Therapeutics, Common

Joint Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Joint Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Joint Stock and Mineralys Therapeutics,

The main advantage of trading using opposite Joint Stock and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Joint Stock position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Joint Stock and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.